Akèy › Metiyè › Regulatory Affairs Managers › Boston, MA
Regulatory Affairs Managers nan Boston, MA: Salè H-1B
44 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Boston, MA. Salè baz medyàn ofri $180,300; mwatye mitan $147,494–$223,718.
Demann (LCA)44
Salè medyan ofri$180,300
Mwatye salè yo$147,494–$223,718
10yèm–90yèm pousantaj$94,082–$292,345
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $91,083 |
| Nivo II (kalifye) | $155,765 |
| Nivo III (eksperyans) | $190,325 |
| Nivo IV (plen kompetans) | $222,435 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 5 | $195,500 |
| argenx US, Inc. | 4 | $182,825 |
| General Hospital Corporation | 3 | $91,083 |
| AstraZeneca Pharmaceuticals LP | 3 | $257,088 |
| CRISPR Therapeutics, Inc. | 3 | $235,000 |
| OW North America LLC | 2 | $127,471 |
| Servier Bio-Innovation LLC | 2 | $260,580 |
| McKinsey & Company, Inc. United States | 2 | $370,450 |
| Rhythm Pharmaceuticals Inc. | 2 | $165,000 |
| Biogen Inc. | 1 | $89,960 |
| Pear Therapeutics, Inc. | 1 | $136,000 |
| Sonos, Inc. | 1 | $111,904 |
| eClinicalWorks LLC | 1 | $180,300 |
| Beth Israel Deaconess Medical Center, Inc. | 1 | $84,897 |
| Elektrofi, Inc. | 1 | $180,294 |
| InGenius LLC | 1 | $89,960 |
| Inozyme Pharma | 1 | $240,000 |
| Wayfair LLC | 1 | $169,251 |
| Praxis Precision Medicines, Inc. | 1 | $225,000 |
| Orsted North America Inc. | 1 | $330,000 |
| PepGen Inc. | 1 | $230,000 |
| Copenhagen Offshore Partners Inc. | 1 | $180,049 |
| Ultragenyx Pharmaceutical, Inc. | 1 | $210,891 |
| Labviva | 1 | $162,000 |
| AVEO Pharmaceuticals, Inc. | 1 | $160,000 |
| EMD Serono Research and Development Institute, Inc. | 1 | $176,000 |
| Alexion Pharmaceuticals, Inc. | 1 | $125,260 |
Tit travay
- Development Manager2
- Program Manager2
- Director, Chemistry Manufacturing Controls2
- Senior Manager, Regulatory Affairs2
- Sr Associate II, Drug Safety1
- Regulatory Senior Specialist1
- Program Sourcing Manager1
- Director - EHR Regulatory Compliance1
- Compliance Technical Specialist1
- Senior Director, Technical Operations1
- Education Project Manager1
- Senior Director Quality Compliance1
- IT Manager Internal Audit1
- Director of Safety/Pharmacovigilance1
- Chemistry Manufacturing Controls Associate Director1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).